dc.creator | Canullo, Luigi | |
dc.creator | Pesce, Paolo | |
dc.creator | Botticelli, Daniele | |
dc.creator | Covani, Ugo | |
dc.creator | Janković, Saša | |
dc.creator | Jovanović, Tanja | |
dc.creator | Rakić, Mia | |
dc.date.accessioned | 2020-07-02T13:17:00Z | |
dc.date.available | 2020-07-02T13:17:00Z | |
dc.date.issued | 2018 | |
dc.identifier.issn | 0882-2786 | |
dc.identifier.uri | https://smile.stomf.bg.ac.rs/handle/123456789/2309 | |
dc.description.abstract | Purpose: To compare the qualitative and quantitative profile of Epstein-Barr virus (EBV) at external and internal implant surfaces between participants with peri-implantitis and healthy peri-implant tissues and to quantitatively assess the relation between EBV and periopathogens inside the microbiologic profile associated with peri-implantitis. Materials and Methods: Microbiologic specimens were retrieved from 84 patients wearing 190 implants to estimate the levels of EBV and 10 periopathogens in the peri-implant pocket and internal-implant connection using quantitative polymerase chain reaction. Results: The study sample consisted of 113 healthy and 77 peri-implantitis-affected implants. Statistical significance was not reached in EBV prevalence between peri-implantitis and healthy controls. EBV-positive participants demonstrated higher levels of Prevotella intermedia (Pi) and Campylobacter rectus (Cr) compared with EBV-negative participants. A positive correlation was demonstrated among EBV and Tannerella forsythia (Tf), Parvimonas micra (Pm), Fusobacterium nucleatum (Fn), and Cr levels in peri-implantitis-affected implants, while healthy controls demonstrated a positive correlation between EBV and Aggregatibacter actinomycetemcomitans (Aa), Pi, and Pm. Conclusion: EBV cannot be considered as a microbiologic marker of peri-implantitis. However, EBV could be considered as a risk factor and a peri-implantitis enhancer based on its positive correlations with pathogens associated with peri-implantitis. | en |
dc.publisher | Quintessence Publishing Co Inc, Hanover Park | |
dc.relation | info:eu-repo/grantAgreement/MESTD/Integrated and Interdisciplinary Research (IIR or III)/41008/RS// | |
dc.relation | info:eu-repo/grantAgreement/MESTD/Basic Research (BR or ON)/173056/RS// | |
dc.rights | restrictedAccess | |
dc.source | International Journal of Oral & Maxillofacial Implants | |
dc.subject | Campylobacter rectus | en |
dc.subject | Epstein-Barr virus infections | en |
dc.subject | Fusobacterium nucleatum | en |
dc.subject | peri-implantitis | en |
dc.subject | Prevotella intermedia | en |
dc.title | What is the Impact of Epstein-Barr Virus in Peri-implant Infection? | en |
dc.type | article | |
dc.rights.license | ARR | |
dcterms.abstract | Песце, Паоло; Ракић, Миа; Јанковић, Саша; Цовани, Уго; Јовановић, Тања; Боттицелли, Даниеле; Цанулло, Луиги; | |
dc.citation.volume | 33 | |
dc.citation.issue | 1 | |
dc.citation.spage | 58 | |
dc.citation.epage | 63 | |
dc.citation.other | 33(1): 58-63 | |
dc.citation.rank | M22 | |
dc.identifier.wos | 000424190000008 | |
dc.identifier.doi | 10.11607/jomi.5972 | |
dc.identifier.pmid | 29340343 | |
dc.identifier.scopus | 2-s2.0-85041856928 | |
dc.type.version | publishedVersion | |